CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
@article{HBSN115373,
author = {Yinhan Wang and Haifeng Xu},
title = {CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease},
journal = {HepatoBiliary Surgery and Nutrition},
volume = {12},
number = {4},
year = {2023},
keywords = {},
abstract = {},
issn = {2304-389X}, url = {https://hbsn.amegroups.org/article/view/115373}
}